Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026. Insmed Incorporated operates in the Healthcare sector. The…

Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Current market data
NASDAQ · INSM
$100.60
Up: +$0.12 · +0.12%
Live quote updated
Keep reading
sec_filing ·
analyst ·
analyst ·
analyst ·